Woebot Health
Woebot Health is a San Francisco-based digital mental health company that licenses a chat-based AI platform delivering CBT, DBT, and IPT-based therapeutic support to healthcare providers, payers, and employers serving adults, adolescents, maternal, and senior populations.
- Company typePrivate
- Founded2017
- HeadquartersSan Francisco, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Woebot Health does
Woebot Health is a San Francisco-based digital mental health company founded in 2017 by clinical research psychologist Dr. Alison Darcy. The company builds a chat-based AI platform that delivers evidence-based therapeutic techniques rooted in Cognitive Behavioral Therapy, Dialectical Behavior Therapy, and Interpersonal Psychotherapy. Its product portfolio includes Woebot for Adults, Woebot for Adolescents (ages 13-17), Woebot for Maternal Health, and Woebot for Adults 65+, supported by B2B modules such as Access Accelerator (clinician-facing EMR integration with patient-reported outcomes capture), Population Health (payer insights), and a Medicare Advantage solution. The underlying technology combines proprietary NLP for concerning language detection with LLM-based input classification that routes users to human-composed, clinically overseen content; generative LLM capabilities are deployed only in IRB-regulated research settings. Woebot's evidence base spans 18+ randomized controlled trials, and the platform holds FDA Breakthrough Device designation, HIPAA and GDPR compliance, and ORCHA certification, though none of its products are FDA-cleared.
Woebot pivoted in June 2025 from a direct-to-consumer subscription model ($39-$49 per month) to a B2B licensing model following a shutdown of its consumer app after serving over 1.5 million users. Revenue is now generated by licensing the platform to healthcare providers, payers, and employers through enterprise contracts, with named health system customers including Akron Children's Hospital, Virtua Health, ChristianaCare, and Hackensack Meridian Health. Distribution is primarily through healthcare provider recommendations, payer and employer wellness programs, and EMR integrations rather than direct consumer acquisition. The company has raised over $123.5 million in total funding across rounds including a $90 million Series B (July 2021, led by Jazz Venture Partners and Temasek) and a $9.5 million strategic investment from Bayer's impact investing arm (March 2022), with a headcount of 51-100 employees.
Woebot Health firmographics
Firmographics- Name
- Woebot Health
- Legal name
- Woebot Health
- Website
- https://woebothealth.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Woebot Health is a San Francisco-based digital mental health company that licenses a chat-based AI platform delivering CBT, DBT, and IPT-based therapeutic support to healthcare providers, payers, and employers serving adults, adolescents, maternal, and senior populations.
- Ownership category
- akta.pro rank
Woebot Health industry classification
Industry- Product category
- Digital Mental Health
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industries
- Health Information Exchange & Public Health Data Integration (HLAJAJAD), HIE Platforms & Network Services (Community/Regional/National) (HLACABAB), Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)
Keywords
Where Woebot Health is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Woebot Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- B2B Platform Licensing: Woebot Health generates revenue by licensing its platform to healthcare providers (health systems, clinics), payers (insurance companies), and employers. The platform is offered as a white-label or branded solution integrated into existing care pathways and employee wellness programs.
- Historical Direct-to-Consumer Subscription: Prior to the June 2025 shutdown, Woebot offered subscription pricing at $39-$49 per month directly to consumers. This model was discontinued due to FDA regulatory costs and the rise of LLMs making the rule-based approach feel outdated.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Former Direct-to-Consumer Premium |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Woebot Health product offering
Product offeringCore offering
Woebot Health provides a chat-based AI mental health platform delivering evidence-based therapeutic techniques (CBT, DBT, IPT) to users as an adjunct to clinical care. Following its June 2025 pivot to a B2B model, the company licenses its platform to healthcare providers, payers, and employers, offering population-specific products (Woebot for Adults, Adolescents, Maternal Health, and Adults 65+) along with B2B solutions (Access Accelerator, Population Health, Medicare Advantage Solution).
Product overview
Woebot Health is an AI-powered digital mental health company offering a suite of chat-based wellness tools. The core offering is the Woebot Health Platform, a foundational development platform that powers multiple product variants. The portfolio includes Woebot for Adults, Woebot for Adolescents, Woebot for Maternal Health, and Woebot for Adults 65+ — each population-specific product built on the shared platform. B2B solutions include Access Accelerator for clinicians (with EMR integration and PRO data collection), Population Health tools for payers and employers, and Medicare Advantage solutions. The company pivoted from direct-to-consumer to B2B in 2025, with products now offered primarily through healthcare providers, employers, and insurers. None of the products are FDA-cleared; all are positioned as adjuncts to clinical care.
Differentiator
Problem solved
Functional benefit
Products and services
- Woebot Health Platform The foundational development platform that powers multiple Woebot mental health products across different regulatory guidances. Provides AI-driven conversational capabilities used to build population-specific digital therapeutic solutions for healthcare providers, payers, and employers.
- Woebot for Adults
Quantifiable outcome
- Over 1.5 million users served before direct-to-consumer shutdown
- +1 more outcomes
Companies that use Woebot Health
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles3 records
Woebot Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature4 records
Woebot Health partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Akron Children's HospitalcoreWoebot Health partnered with Akron Children's Hospital to provide Woebot for Adolescents (ages 13-17) as a free mental health support tool for teen patients. The partnership addresses the mental health provider shortage for adolescents.
- Virtua HealthcoreVirtua Health partnered with Woebot Health to offer Woebot for Adults to patients, featuring the app in 60 Minutes coverage and NJ Spotlight News reports.
- ChristianaCarecoreChristianaCare partnered with Woebot Health to provide provider training and deployment of Woebot for Adults for their patient population.
- Hackensack Meridian HealthcoreHackensack Meridian Health partnered with Woebot Health to provide provider training and deployment of Woebot for Adults for their patient population.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Woebot Health competitors and assessment
Company assessmentBroad incumbents
- Calm Health: Consumer and enterprise mental wellness platform with meditation, sleep, and now employer mental health benefits. Broader and less clinically specialized than Woebot but competes for the same employer wellness dollar.
- Headspace Health: Large-scale mental health platform combining consumer content, meditation, and therapy services (including the Ginger acquisition). Competes with Woebot in employer, payer, and health system channels with a broader, less AI-specialized offering.
Direct peers
- Wysa: AI-driven chat-based mental health chatbot delivering CBT-based support to consumers, payers, and employers. Most direct competitor in the conversational mental health AI category, serving similar populations including adolescents and workplace mental health.
- Lyra Health: Mental health benefits platform for employers and payers combining provider matching, live therapy, and digital self-service. Targets the same payer/employer buyer as Woebot's B2B motion and includes digital coaching tools analogous to Woebot.
- Spring Health: Employer- and payer-facing mental health benefits platform offering assessments, digital exercises, and provider matching. Competes with Woebot for the same employer wellness and payer population health budgets.
- Talkspace: Online therapy platform serving payers, employers, and individuals via text/audio/video with therapists. Comparable B2B2C model and overlap in payer and employer distribution channels, though primarily human-delivered rather than AI-led.
- Tess (X2AI): Conversational AI mental health chatbot delivering CBT, DBT, and psychoeducation via chat, with health system and employer deployments. Closest technology analog to Woebot's rule-based, human-authored CBT dialogue approach.
Emerging players
- Big Health (Sleepio): Digital therapeutic company focused on insomnia and anxiety, with FDA-cleared assets and enterprise distribution through payers and employers. Competes for similar digital therapeutic budgets and demonstrates the FDA-cleared DTx path Woebot has not pursued.
- Cerebral: Online mental health provider offering therapy and medication management with an emphasis on anxiety and depression treatment. Targets similar patient populations and has overlapping payer relationships, though delivery is clinician-led rather than AI-first.
- Meru Health: Digital mental health clinic combining clinician-led care with digital therapeutic exercises, sold to payers and employers. Comparable B2B digital therapeutic model and population health orientation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Woebot Health social profiles
Digital presenceWoebot Health compliance and trust
Trust signalCompliance2 records
Woebot Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Woebot Health leadership team
Management profileNumber of profiles
Profiles15 records
Woebot Health funding detail
Funding detailFunding overview
Funding rounds4 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Woebot Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Woebot Health
What does Woebot Health do?
Woebot Health provides a chat-based AI mental health platform delivering evidence-based therapeutic techniques (CBT, DBT, IPT) to users as an adjunct to clinical care. Following its June 2025 pivot to a B2B model, the company licenses its platform to healthcare providers, payers, and employers, offering population-specific products (Woebot for Adults, Adolescents, Maternal Health, and Adults 65+) along with B2B solutions (Access Accelerator, Population Health, Medicare Advantage Solution).
Is Woebot Health a public or private company?
Woebot Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Woebot Health founded?
Woebot Health was founded in 2017. It employs 51 to 100 people.
Where is Woebot Health based?
Woebot Health is headquartered in San Francisco, United States, in the North America region.
How does Woebot Health make money?
Two revenue lines are on record. B2B Platform Licensing is the primary driver. The others are historical Direct-to-Consumer Subscription.
Who are Woebot Health's main competitors?
Broad incumbents on record are Calm Health and Headspace Health. Direct peers are Wysa, Lyra Health, Spring Health, Talkspace and Tess (X2AI). Emerging players are Big Health (Sleepio), Cerebral and Meru Health.
Does Woebot Health have an API?
No public API is recorded for Woebot Health.
What industry is Woebot Health in?
Woebot Health's product category is Digital Mental Health. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLAJAJAD, Health Information Exchange & Public Health Data Integration. Its NAICS code is 621420 and its SIC code is 7372.